KR950701924A - 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법 - Google Patents

신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법

Info

Publication number
KR950701924A
KR950701924A KR1019940704495A KR19940704495A KR950701924A KR 950701924 A KR950701924 A KR 950701924A KR 1019940704495 A KR1019940704495 A KR 1019940704495A KR 19940704495 A KR19940704495 A KR 19940704495A KR 950701924 A KR950701924 A KR 950701924A
Authority
KR
South Korea
Prior art keywords
derivative
eburnamenin
manufacturing
pharmaceutical composition
composition containing
Prior art date
Application number
KR1019940704495A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950701924A publication Critical patent/KR950701924A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
KR1019940704495A 1992-06-09 1994-12-09 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법 KR950701924A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9201911A HU209678B (en) 1992-06-09 1992-06-09 Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them
PCT/HU1993/000036 WO1993025550A1 (en) 1992-06-09 1993-06-08 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same

Publications (1)

Publication Number Publication Date
KR950701924A true KR950701924A (ko) 1995-05-17

Family

ID=10982021

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704495A KR950701924A (ko) 1992-06-09 1994-12-09 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법

Country Status (18)

Country Link
US (1) US5510345A (ko)
EP (1) EP0644885A1 (ko)
JP (1) JPH07507793A (ko)
KR (1) KR950701924A (ko)
AU (1) AU4352493A (ko)
CA (1) CA2136547A1 (ko)
CZ (1) CZ307994A3 (ko)
EE (1) EE9400070A (ko)
FI (1) FI945780A0 (ko)
GR (1) GR1001597B (ko)
HR (1) HRP930957A2 (ko)
HU (1) HU209678B (ko)
IL (1) IL105942A0 (ko)
LT (1) LT3118B (ko)
NZ (1) NZ253308A (ko)
SI (1) SI9300309A (ko)
WO (1) WO1993025550A1 (ko)
ZA (1) ZA934037B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200626139A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
JP5149009B2 (ja) 2004-09-20 2013-02-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
TW200626592A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
AU2005286592A1 (en) * 2004-09-23 2006-03-30 Reddy Us Therapeutics, Inc. Novel pyrimidine compounds, process for their preparation and compositions containing them
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US20110053907A1 (en) * 2008-03-27 2011-03-03 Auckland Uniservices Limited Substituted pyrimidines and triazines and their use in cancer therapy
CN101928286A (zh) * 2009-06-18 2010-12-29 谢开智 长春胺衍生物及制备方法
CN105492008B (zh) 2013-03-13 2020-11-27 福马治疗股份有限公司 用于抑制fasn的化合物及组合物
CA3026149A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
AR110770A1 (es) 2017-01-23 2019-05-02 Cadent Therapeutics Inc Moduladores del canal de potasio
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2176516B1 (ko) * 1972-03-22 1975-03-14 Synthelabo
HU171663B (hu) * 1975-09-01 1978-02-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
WO1987001706A2 (en) 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
WO1987007895A1 (en) 1986-06-23 1987-12-30 The Upjohn Company Androstane-type and cortical aminoesters
WO1988007527A1 (en) 1987-04-03 1988-10-06 The Upjohn Company Amino-9,10-secosteroids
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
FR2644789B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644787B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644788B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
AU642711B2 (en) 1990-01-26 1993-10-28 Upjohn Company, The 5-oxygenated-2,4,6-triaminopyrimidines

Also Published As

Publication number Publication date
ZA934037B (en) 1994-01-06
HRP930957A2 (en) 1995-02-28
HU209678B (en) 1994-10-28
US5510345A (en) 1996-04-23
LTIP599A (en) 1994-07-15
EE9400070A (et) 1995-12-15
HU9201911D0 (en) 1992-09-28
CA2136547A1 (en) 1993-12-23
FI945780A (fi) 1994-12-08
EP0644885A1 (en) 1995-03-29
GR1001597B (el) 1994-06-30
IL105942A0 (en) 1993-10-20
LT3118B (en) 1994-12-27
NZ253308A (en) 1995-11-27
SI9300309A (sl) 1993-12-31
JPH07507793A (ja) 1995-08-31
HUT64540A (en) 1994-01-28
AU4352493A (en) 1994-01-04
WO1993025550A1 (en) 1993-12-23
FI945780A0 (fi) 1994-12-08
CZ307994A3 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
BR1100824A (pt) Composto e composição farmacêutica
BR1100329A (pt) Composto e formulação farmacêutica
FI944832A0 (fi) Farmaseuttinen koostumus
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
EP0494654A3 (en) Stable pharmaceutical composition and method for its production
FI930882A (fi) Farmaceutiska foereningar
BR9200058A (pt) Composto e composicao farmaceutica
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
FI931251A (fi) Farmaceutiska foereningar
UA26064A1 (uk) Фармацевтичhа композиція
DE69329749T2 (de) Cycloolefincopolymer-zusammensetzung und deren herstellung
KR900009580A (ko) 벤젠 유도체, 그 제조방법 및 그를 함유하는 약학 조성물
DE69326721T2 (de) Insektizidzusammensetzung
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DE69117519D1 (de) 14-o-p-chlorbenzoylaconin und analgetischer/entzündungshemmender wirkstoff
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922581A1 (it) Composizione farmaceutica

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid